BYD is selling so many electric cars it’s become one of the top three automakers in China

BYD is selling so many electric cars it’s become one of the top three automakers in China


One of BYD’s bestselling electric car models, the Han, is on display during an auto show in Shenzhen on June 5, 2022.

Anadolu Agency | Anadolu Agency | Getty Images

BEIJING — Chinese electric car maker BYD saw sales more than double in May, solidifying the company’s climb into the ranks of the top three automakers in China.

That’s according to data by the China Passenger Car Association which was released Friday. China is the world’s largest auto market.

Backed by Warren Buffett’s Berkshire Hathaway, BYD is also a battery maker that’s become a major electric car brand in China — and some of its models are vying with Tesla in popularity.

So far this year, not only has BYD continued to dominate new energy vehicles, which include hybrid and battery-powered cars, but the company also climbed into the ranks of the top three brands in China by passenger car sales.

Despite Covid lockdowns that hit supply chains and Chinese consumer sentiment, BYD sold 113,768 new energy passenger cars last month, the data showed.

Whether in SUVs or smaller passenger cars, BYD accounted for two of the top three bestselling new energy models in China last month, according to association data. Tesla, Nio and Xpeng didn’t make the cut.

Those sales put BYD into second place in China’s passenger car market overall — just behind FAW-Volkswagen, with 150,009 cars sold, according to the data. FAW-Volkswagen is the German automaker’s joint venture in China that sells the Audi and Volkswagen branded vehicles.

BYD’s sales marked a 159.5% year-on-year increase, while FAW-Volkswagen’s fell 10.6% from May last year. Geely was the third-largest by passenger car sales, at 73,315, down 14.5%.

Last year, BYD ranked 13th by passenger car sales. FAW-Volkswagen, SAIC Volkswagen and SAIC GM took the top three spots.

Read more about electric vehicles from CNBC Pro

In the U.S. passenger car market, Tesla did not make the top three spots. Toyota ranks first by sales, followed by Ford and General Motors’ Chevrolet brand, according to Sino Auto Insights.

China’s passenger car sales fell 11.8% in May from a year ago, while new energy vehicles saw sales climb 91.2%, according to the passenger car association.

For the first five months of the year, FAW-Volkswagen ranked first by sales, followed by BYD and then Changan Automobile, the data showed.

Within new energy vehicles, BYD ranked first, followed by General Motors’ joint venture with Wuling Motors and state-owned SAIC Motor. Tesla China ranked third.



Source

PayPal beats on earnings, raises full-year outlook as Venmo growth accelerates
World

PayPal beats on earnings, raises full-year outlook as Venmo growth accelerates

PayPal reported better-than-expected results for the second quarter and raised its full-year guidance for transaction margin dollars and earnings per share. The stock slipped more than 4% following the report. Here’s how the company did compared with Wall Street estimates, based on a survey of analysts by LSEG: Earnings per share: $1.40 adjusted vs. $1.30 expected […]

Read More
Novo Nordisk shares plunge 17% after Wegovy-maker cuts full-year guidance
World

Novo Nordisk shares plunge 17% after Wegovy-maker cuts full-year guidance

Medical bottles and a syringe are seen with the Novo Nordisk logo displayed on a screen in the background. Nurphoto | Nurphoto | Getty Images Danish pharmaceutical giant Novo Nordisk on Tuesday cut its full-year sales and profit guidance, citing weaker growth expectations for its Wegovy obesity drug in the key U.S. market. Shares were […]

Read More
Pharma giants push for tariff clarity as ambiguity threatens EU-U.S. deal
World

Pharma giants push for tariff clarity as ambiguity threatens EU-U.S. deal

Shelf of pharmaceutical products. D3sign | Moment | Getty Images Pharma firms are calling for clarity on tariffs imposed under the new U.S.-EU trade agreement, as analysts warn that punitive sector-specific levies could risk blowing up the entire deal. Ambiguity abounds around the terms for pharmaceutical goods under the trade truce agreed Sunday, which imposes […]

Read More